Articles
2022
October 24, 2022
Read about NervGen and its research in Alzheimer’s in this article in Health Europa
July 29, 2022
Read about NervGen in this article in Genetic Engineering and Biotechnology News
July 29, 2022
Read about NervGen and our preclinical results in stroke in this article in BioSpace
July 28, 2022
New Scientist’s Carissa Wong writes about NervGen’s potential in stroke following Cell Reports publication
July 28, 2022
Read about NervGen in Fierce Biotech and the recent study published in stroke
July 18, 2022
Article in Contract Pharma by NervGen President & CEO, Paul Brennan, on the role of Biotech in improving Stroke outcomes.
June 22, 2022
Brain Fitness Facts – North American Precis Syndicate.
June 16, 2022
Article by NervGen President & CEO, Paul Brennan is featured in Grit Daily.
June 10, 2022
NervGen is featured in News Financial.
May 16, 2022
Read about NervGen in this BioSpace article.
April 15, 2022
Startup Savant interviews NervGen Co-Founder, Dr. Harold Punnett.
April 8, 2022
NervGen is featured in Multiple Sclerosis News Today.
April 7, 2022
Technology Networks features article by NervGen President & CEO, Paul Brennan.
April 2, 2022
Grit Daily features article by NervGen President & CEO, Paul Brennan.
March 24, 2022
Authority Magazine interviews NervGen Co-Founder Dr. Harold Punnett.
2021
June 25, 2021
Authority Magazine interviews Paul Brennan about the company and its technology.
May 7, 2021
North American Precis Syndicate
North American Precis Syndicate features NervGen’s technology and Alzheimer’s disease.
April 16, 2021
BioProcess International
BioProcess International features a byline from Paul Brennan.
April 7, 2021
Grit Daily
Grit Daily features a byline from Paul Brennan.
April 1, 2021
Longevity Technology
Longevity Technology features NervGen and its technology.
February 3, 2021
BioProcess International
BioProcess International features a byline from Paul Brennan.
January 7, 2021
Grit Daily
Grit Daily features a byline from Paul Brennan.